Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL728223 | 0.72 | NPC1 (0.39) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL5228519 | 0.72 | HTR2C (0.39) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL7973057 | 0.72 | HSD11B1 (0.36) | ALDH1A1NPC1RAB9A | |
| SCHEMBL731336 | 0.72 | NPC1 (0.50) | ALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL17756329 | 0.69 | IDO1 (0.58) | IDO1FOLH1 | |
| SCHEMBL441726 | 0.69 | IDO1 (0.58) | IDO1FOLH1 | |
| SCHEMBL17756332 | 0.69 | IDO1 (0.58) | IDO1FOLH1 | |
| SCHEMBL24923799 | 0.68 | ALDH1A1 (0.44) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL10697684 | 0.68 | KIF11 (0.41) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL8649025 | 0.68 | PTGS2 (0.42) | ALDH1A1MEN1MAPK1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0904269-B1 | 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS | MERCK FROSST CANADA INC (CA) | 2002-01-23 | — | — | EP | disclosed |
| US-6057319-A | CYCLOOXYGENASE-2 INHIBITORS; NON-STEROIDAL ANTIINFLAMMATORY AGENTS | MERCK FROSST CANADA & CO. (CA) | 2000-05-02 | — | — | US | disclosed |
| EP-0904269-A1 | 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1999-03-31 | — | — | EP | disclosed |
| EP-0863134-A1 | 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2 | MERCK FROSST CANADA INC. (CA) | 1998-09-09 | — | — | EP | disclosed |
| US-5698584-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS | MERCK FROSST CANADA, INC. (CA) | 1997-12-16 | — | — | US | disclosed |
| WO-1997016435-A1 | 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1997-05-09 | — | — | WO | disclosed |